Clinical Trials Directory

Trials / Completed

CompletedNCT01895114

Assessment of Renal Function in Cirrhotic Patients

Assessment of Renal Function in Cirrhotic Patients -A Comparison of Cystatin C and Creatinine Based Calculations to 125I-iothalamate

Status
Completed
Phase
Study type
Observational
Enrollment
213 (actual)
Sponsor
Baylor Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to help determine whether cystatin C is a more sensitive laboratory measurement for renal function in cirrhotic patients.

Detailed description

Serum cystatin C, creatinine clearance based calculations, and 125I-Iothalamate clearance (Glofil) will be obtained in 220 patients with cirrhosis. Utilizing this information, the correlation between cystatin C and 125I-Iothalamate clearance will be obtained. In addition, the current serum creatinine based calculations and true creatinine clearance will also be correlated with 125I-Iothalamate clearance. The results of this study should help to determine whether serum cystatin C is a more sensitive laboratory measurement of renal function in patients with cirrhosis.

Conditions

Timeline

Start date
2010-12-01
Primary completion
2021-04-01
Completion
2025-01-13
First posted
2013-07-10
Last updated
2025-10-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01895114. Inclusion in this directory is not an endorsement.

Assessment of Renal Function in Cirrhotic Patients (NCT01895114) · Clinical Trials Directory